Reply to D. O'Reilly et al.

Autor: Patel A; Amol Patel, MD, DM, Army Hospital Research & Referral, New Delhi, India; Vineet Govinda Gupta, MD, DM, Artemis Hospitals, Gurugram, India; Bivas Biswas, MD, DM; and Sandip Ganguly, MD, DM, Tata Medical Center, Kolkata, India; Chandan K. Das, MD, DM, Post Graduate Institute of Medical Education and Research, Chandigarh, India; Atul Batra, MD, DM, All India Institute of Medical Sciences, New Delhi, India; and Sainath Bhethanabhotla, MD, DM, Care Cancer Institute, Hyderabad, India., Gupta VG; Amol Patel, MD, DM, Army Hospital Research & Referral, New Delhi, India; Vineet Govinda Gupta, MD, DM, Artemis Hospitals, Gurugram, India; Bivas Biswas, MD, DM; and Sandip Ganguly, MD, DM, Tata Medical Center, Kolkata, India; Chandan K. Das, MD, DM, Post Graduate Institute of Medical Education and Research, Chandigarh, India; Atul Batra, MD, DM, All India Institute of Medical Sciences, New Delhi, India; and Sainath Bhethanabhotla, MD, DM, Care Cancer Institute, Hyderabad, India., Biswas B; Amol Patel, MD, DM, Army Hospital Research & Referral, New Delhi, India; Vineet Govinda Gupta, MD, DM, Artemis Hospitals, Gurugram, India; Bivas Biswas, MD, DM; and Sandip Ganguly, MD, DM, Tata Medical Center, Kolkata, India; Chandan K. Das, MD, DM, Post Graduate Institute of Medical Education and Research, Chandigarh, India; Atul Batra, MD, DM, All India Institute of Medical Sciences, New Delhi, India; and Sainath Bhethanabhotla, MD, DM, Care Cancer Institute, Hyderabad, India., Ganguly S; Amol Patel, MD, DM, Army Hospital Research & Referral, New Delhi, India; Vineet Govinda Gupta, MD, DM, Artemis Hospitals, Gurugram, India; Bivas Biswas, MD, DM; and Sandip Ganguly, MD, DM, Tata Medical Center, Kolkata, India; Chandan K. Das, MD, DM, Post Graduate Institute of Medical Education and Research, Chandigarh, India; Atul Batra, MD, DM, All India Institute of Medical Sciences, New Delhi, India; and Sainath Bhethanabhotla, MD, DM, Care Cancer Institute, Hyderabad, India., Das CK; Amol Patel, MD, DM, Army Hospital Research & Referral, New Delhi, India; Vineet Govinda Gupta, MD, DM, Artemis Hospitals, Gurugram, India; Bivas Biswas, MD, DM; and Sandip Ganguly, MD, DM, Tata Medical Center, Kolkata, India; Chandan K. Das, MD, DM, Post Graduate Institute of Medical Education and Research, Chandigarh, India; Atul Batra, MD, DM, All India Institute of Medical Sciences, New Delhi, India; and Sainath Bhethanabhotla, MD, DM, Care Cancer Institute, Hyderabad, India., Batra A; Amol Patel, MD, DM, Army Hospital Research & Referral, New Delhi, India; Vineet Govinda Gupta, MD, DM, Artemis Hospitals, Gurugram, India; Bivas Biswas, MD, DM; and Sandip Ganguly, MD, DM, Tata Medical Center, Kolkata, India; Chandan K. Das, MD, DM, Post Graduate Institute of Medical Education and Research, Chandigarh, India; Atul Batra, MD, DM, All India Institute of Medical Sciences, New Delhi, India; and Sainath Bhethanabhotla, MD, DM, Care Cancer Institute, Hyderabad, India., Bhethanabhotla S; Amol Patel, MD, DM, Army Hospital Research & Referral, New Delhi, India; Vineet Govinda Gupta, MD, DM, Artemis Hospitals, Gurugram, India; Bivas Biswas, MD, DM; and Sandip Ganguly, MD, DM, Tata Medical Center, Kolkata, India; Chandan K. Das, MD, DM, Post Graduate Institute of Medical Education and Research, Chandigarh, India; Atul Batra, MD, DM, All India Institute of Medical Sciences, New Delhi, India; and Sainath Bhethanabhotla, MD, DM, Care Cancer Institute, Hyderabad, India.
Jazyk: angličtina
Zdroj: JCO global oncology [JCO Glob Oncol] 2021 Apr; Vol. 7, pp. 648.
DOI: 10.1200/GO.21.00077
Abstrakt: Competing Interests: Sainath BhethanabhotlaStock and Other Ownership Interests: Merck, Pfizer, AstraZenecaNo other potential conflicts of interest were reported.
Databáze: MEDLINE